ID: ALA3277270

Max Phase: Preclinical

Molecular Formula: C18H23Cl2NO2S

Molecular Weight: 351.90

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.OC(CNCCSCc1ccccc1)COc1ccccc1Cl

Standard InChI:  InChI=1S/C18H22ClNO2S.ClH/c19-17-8-4-5-9-18(17)22-13-16(21)12-20-10-11-23-14-15-6-2-1-3-7-15;/h1-9,16,20-21H,10-14H2;1H

Standard InChI Key:  RQHCGTWUKSCCGM-UHFFFAOYSA-N

Associated Targets(non-human)

Felis catus 3858 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 351.90Molecular Weight (Monoisotopic): 351.1060AlogP: 3.60#Rotatable Bonds: 10
Polar Surface Area: 41.49Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.22CX LogP: 3.84CX LogD: 2.03
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.64Np Likeness Score: -1.29

References

1. Tucker H, Coope JF..  (1978)  beta-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols.,  21  (8): [PMID:29123] [10.1021/jm00206a010]

Source